-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

634A.O2.6 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Personalized and Molecular Approaches in Myeloproliferative Neoplasms: Risk Stratification and Therapeutic Implications

Symposia: Myeloproliferative Syndromes: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Adult, Clinical Practice (Health Services and Quality), MPN, Epidemiology, Genomics, Clinical Research, Chronic Myeloid Malignancies, Diseases, Treatment Considerations, Real-world evidence, Non-Biological therapies, Biological Processes, Myeloid Malignancies, Multi-systemic interactions, Study Population, Human
Saturday, December 7, 2024: 2:00 PM-3:30 PM
Ballroom 20AB (San Diego Convention Center)
Moderators:
Lucia Masarova, MD, University of Texas MD Anderson Cancer Center and James T England, MD, MSc, FRCPC, ARRAY(0xf357518)
Disclosures:
Masarova: MorphoSys: Other: Advisory Board Participant; Cogent: Other: Advisory Board Participant; GSK: Consultancy, Other: Travel support; PharmaEssentia: Other: Advisory Board Participant. England: GSK: Honoraria; Novartis: Honoraria.
2:00 PM

Marta Santaliestra1*, Marta Garrote2*, María Soledad Noya3*, Manuel Pérez-Encinas4*, María Alicia Senin5*, Raul Perez Lopez6*, Francisca Ferrer Marin, MD7,8, Gonzalo Carreño, PhD9*, Gonzalo Caballero Navarro10*, Elena Magro11*, Patricia Velez, MD12*, Miguel A. Cortes Vázquez13*, Ana Moreto Quintana14*, Anna Angona15*, Irene Pastor Galan16*, Jose María Guerra17*, M. Carmen Garcia Hernandez18*, María Isabel Mata19*, Ruth Stuckey, PhD20*, Maria Teresa Gómez Casares21*, Maria Laura Fox, MD22*, Beatriz Cuevas23*, Valentín García Gutiérrez Sr.24, Ana Triguero25*, Eduardo Arellano-Rodrigo26*, Juan Carlos Hernandez Boluda, MD, PhD27* and Alberto Alvarez-Larran28*

1Hospital Universitari Mútua Terrassa, Barcelona, Spain
2Hematopathology Section, Pathology Department, Hospital Clínic Barcelona, Barcelona, Spain
3Complexo Hospitalario Universitario de A Coruña, A Coruña, Spain
4Hospital Clínico Universitario, Santiago de Compostela, Spain., Santiago, Spain
5Hospital del Mar, Barcelona, Spain
6Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
7UCAM, Murcia, Spain
8Hospital Universitario Morales Meseguer. Centro Regional de Hemodonación. Universidad de Murcia. IMIB-Arrixaca, Murcia, Spain
9Hospital Universitario 12 de Octubre, Madrid, Spain
10Hematology Department. Hospital Miguel Servet, Zaragoza, Spain., Zaragoza, ESP
11Hematology Department. Hospital Príncipe de Asturias, Alcalá de Henares, Spain., Alcalá de Henares, Spain
12Department of Hematology, Hospital del Mar, Barcelona, Spain
13Hematology Department. Hospital Marqués de Valdecilla, Santander, Spain, Santander, Spain
14Hospital Universitario de Cruces, Barakaldo, Spain
15Hospital Universitario Doctor Josep Trueta - ICO, Girona, Spain
16Department of Hematology, Hospital Clínico Universitario-INCLIVA, Valencia, ESP
17Hospital Son Llatzer, Palma de Mallorca, Spain
18Hematology Department, Hospital General Universitario de Alicante, Alicante, ESP
19Hematology Department. Hospital Costa del Sol, Marbella, Spain, Marbella, Spain
20Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas, Spain
21Hospital Universitario Doctor Negrín, Las Palmas, Spain
22Hematology Department, Vall d'Hebron University Hospital, University Autònoma of Barcelona (UAB), Barcelona, Spain
23Hospital de Burgos, BURGOS, ESP
24Hematology, Hospital Universitario Ramón y Cajal, Madrid, Spain
25Hospital Clínic de Barcelona, Barcelona, Spain
26Department of Hemotherapy and Hemostasis, Hospital Clinic, Barcelona, Spain
27Hospital Clínico Universitario-INCLIVA, VALENCIA, Spain
28Hematoloy Department,, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain

2:15 PM

Francesca Palandri, MD, PhD1*, Elena Maria Elli, MD2*, Giulia Benevolo, MD3*, Alessandra Dedola4,5*, Roberto Latagliata6*, Erika Morsia7*, Mario Tiribelli, MD8*, Francesco Cavazzini, MD9*, Alessia Tieghi, MD10*, Mirko Farina, MD11*, Alessandra D'Addio, MD12*, Elisabetta Abruzzese, MD13, Fabrizio Cavalca14*, Rikard Mullai, MD15*, Antonio Cuneo, MD16*, Bruno Martino, MD17*, Florian Heidel, MD18, Elena Rossi, MD19*, Massimo Breccia20*, Valerio De Stefano, MD19* and Filippo Branzanti, MSc5,21*

1IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Istituto di Ematologia "Seràgnoli", Bologna, Italy
2Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
3Hematology Division I, Department of Molecular Biotechnologies and Health Sciences, University of Turin/University Hospital A.O.U. “Città della Salute e della Scienza”, Turin, Italy
4IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Bologna, Italy
5Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Bologna, Italy
6Hematology Unit, Ospedale Belcolle, Viterbo, Italy, Rome, ITA
7Hematology Unit, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Ancona, Italy
8Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy
9Division of Hematology, Arcispedale Sant'Anna, University of Ferrara, Ferrara, ITA
10Department of Hematology, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy
11Unit of Blood Diseases and Bone Marrow Transplantation, Cell Therapies and Hematology Research Program, Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy
12Division of Hematology, Onco-hematologic Department, AUSL della Romagna, Ravenna, Ravenna, ITA
13Division of Hematology, Ospedale S. Eugenio, Roma, Roma, Italy
14IRCCS San Gerardo dei Tintori, divisione di ematologia e unità trapianto di midollo, Monza, Monza, Italy
15Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Udine, Italy
16Division of Hematology, University of Ferrara, Ferrara, Ferrara, Italy
17Division of Hematology, Azienda Ospedaliera 'Bianchi Melacrino Morelli', Reggio Calabria, Italy
18Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Hannover Medical School (MHH), Hannover, Hannover, Germany
19Fondazione Policlinico Gemelli IRCCS, Section of Hematology, Catholic University, Rome, Roma, Italy
20Department of Translational and Precision Medicine, Az., Hematology-Sapienza University, Rome, Italy
21IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy

2:30 PM

Shivani Handa, MD1,2, Yosef Joseph Rene Amel Riazat-Kesh, MD3, Richard J Butterfield4,5*, Ganesh Sivakumar, MD6*, Sangeetha Venugopal, MD, MS7, Erin McGovern, BA5,8*, Jonathan Feld, MD1, Douglas Tremblay, MD1, Sebastian Elghaity-Beckley1*, Marina Kremyanskaya, MD, PhD1,5, John O. Mascarenhas, MD1,5, Blake Langlais, MS4,5*, Gina L. Mazza, PhD4,5*, Daniel I. Nathan, MD1, Joseph Tripodi, PhD9, Vesna Najfeld, PhD5,10, Amylou C Dueck, PhD4,5, Raajit Rampal, MD, PhD5,8, Ronald Hoffman, MD1,5 and Bridget Kelly Marcellino, MD, PhD1,5

1Division of Hematology & Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
2Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH
3Weill Cornell Medical Center - NewYork-Presbyterian, New York
4Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ
5Myeloproliferative Neoplasms (MPN) Research Consortium, New York, NY
6Department of Internal Medicine, Icahn School of Medicine/ Mount Sinai Morningside-West, New York, NY
7Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
8Memorial Sloan Kettering Cancer Center, New York, NY
9Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, Old Tappan, NJ
10Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY

2:45 PM

Ayalew Tefferi, MD1, Maymona Abdelmagid, MD2*, Giuseppe Gaetano Loscocco3*, Kebede Begna, MD2, Aref Al-Kali, MD1, James M. Foran, MD4, Jeanne Palmer, MD5, Talha Badar, MD6, Mrinal M. Patnaik, MD, MBBS7, Kaaren K. Reichard, MD8, Rong He, MD9, Cinthya Zepeda Mendoza, PhD2*, Mithun V Shah, M.D., Ph.D.1, Attilio Orazi, MD10*, Daniel A. Arber, MD11, Animesh D. Pardanani, MBBS, PhD2, Alessandro M. Vannucchi, MD, PhD12, Devendra Hiwase, MD, MBBS, PhD, FRACP, FRCPA13, Naseema Gangat, MBBS1 and Paola Guglielmelli, MD14

1Division of Hematology, Mayo Clinic, Rochester, MN
2Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
3Department of Experimental and Clinical Hematology, Centro di Ricerca e Innovazione Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Florence, Italy
4Division of Hematology & Medical Oncology, Mayo Clinic, Jacksonville, FL
5Mayo Clinic - Arizona, Scottsdale, AZ
6Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
7Mayo Clinic, Rochester, MN
8Department of Pathology, Mayo Clinic, Rochester, MN
9Division of Hematopathology, Mayo Clinic, Rochester, MN
10Texas Tech University Health Sciences Center, El Paso
11University of Chicago, Chicago, IL
12Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy
13Royal Adelaide Hospital, Adelaide, SA, Australia
14Department of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Florence, Italy

3:00 PM

Nico Gagelmann, MD1*, Barbara Mora2*, Filippo Branzanti, MSc3*, Alessandro Maria Vannucchi4, Massimo Breccia5*, Giuseppe Alberto Maria Palumbo6*, Massimiliano Bonifacio, MD7*, Erika Morsia8*, Elena Maria Elli, MD9*, Mario Tiribelli, MD10*, Giulia Benevolo, MD11*, Mirko Farina, MD12*, Fabrizio Pane13, Roberto Massimo Lemoli, MD14*, Giovanni Caocci, MD15, Alessia Tieghi, MD16*, Gianni Binotto, MD17*, Francesco Cavazzini, MD18*, Bruno Martino, MD19*, Alessandro Isidori, MD, PhD20, Margherita Maffioli21*, Elisa Rumi, MD22*, Tiziano Barbui, MD23*, Francisco Cervantes24*, Matteo Giovanni Della Porta, MD25*, Andrew T. Kuykendall, MD26, Marianna Caramella, MD27*, Alessandra Iurlo, MD, PhD28*, Valerio De Stefano, MD29*, Jean-Jacques Kiladjian, MD, PhD30, David Ross, MD31, Jason Gotlib, MD, MS32, Timothy Devos, MD, PhD33*, Marco Ruggeri, MD34*, Richard T. Silver, MD35, Rachel B. Salit, MD36, Thomas Schroeder37*, Carmelo Gurnari, MD, PhD38, Simona Pagliuca, MD, PhD39, Christina Rautenberg40*, Marie Robin, MD41*, Marie-Thérèse Rubio, MD, PhD42*, Jaroslaw Maciejewski43, Alessandro Rambaldi44, Maria Chiara Finazzi44*, Andrea Bacigalupo, MD45, Patrizia Chiusolo, MD, PhD45*, Hans Christian Reinhardt, MD46, Bart L. Scott, MD47, Nicolaus Kröger, MD Prof48*, Francesco Passamonti, MD49* and Francesca Palandri, MD, PhD50*

1Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany
2Fondazione I.R.C.C.S. Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy
3IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
4Department of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Firenze, Tuscany, Italy
5Department of Translational and Precision Medicine, Az., Hematology-Sapienza University, Rome, Italy
6Universtiy Hospital Catania, Catania, ITA
7Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy
8Hematology Unit, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Ancona, Italy
9Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
10Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy
11Hematology Division I, Department of Molecular Biotechnologies and Health Sciences, University of Turin/University Hospital A.O.U. “Città della Salute e della Scienza”, Turin, Italy
12Unit of Blood Diseases and Bone Marrow Transplantation, Cell Therapies and Hematology Research Program, Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, University of Brescia, ASST Spedali Civili, Brescia, Italy
13Division of Hematology and SCT Unit, Federico II University, Naples, Naples, Italy
14Clinic of Hematology, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Genoa, Italy
15University of Cagliari, Monserrato, Italy
16Department of Hematology, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Reggio Emilia, ITA
17Department of Medicine, Hematology and Clinical Immunology, University of Padua, Padua, Italy
18Università degli Studi di Ferrara, Ferrara, Italy
19Division of Hematology, Azienda Ospedaliera 'Bianchi Melacrino Morelli', Reggio Calabria, Italy
20AST Pesaro e Urbino, Hematology and Stem Cell Transplant Center, Pesaro, PU, Italy
21ASST Dei Sette Laghi, Ospedale Di Circolo, Varese, Varese, ITA
22Department of Molecular Medicine, University of Pavia, Pavia, Italy
23FROM Research Foundation ASST Papa Giovanni XXIII Bergamo, Bergamo, ITA
24Hospital Clinic, Barcelona, Spain
25IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
26Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
27Divisione Ematologia, Ospedale Niguarda, Milan, Italy
28Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
29Institute of Hematology, Catholic University School of Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Roma, Italy
30Hopital Saint-Louis, Paris, France
31Royal Adelaide Hospital, Adelaide, Australia
32Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA
33University Hospitals Leuven (UZ Leuven), Leuven, BEL
34San Bortolo Hospital, Vicenza, ITA
35Richard T. Silver, MD Myeloproliferative Neoplasms Center, Weill Cornell Medicine, New York, NY
36Fred Hutchinson Cancer Research Center, Seattle, WA
37Dept. of Hematology and Stem Cell Transplantation West German Cancer Centre University Hospital Essen Essen, Germany, Duisburg, Germany
38Cleveland Clinic Foundation, Cleveland, OH
39Department of Hematology, Nancy University Hospital, Vandœuvre-lès-Nancy, France, France
40Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
41Hopital Saint Louis, APHP, Paris, France
42BMT Unit, Nancy, France
43Taussig Cancer Center, Cleveland, OH
44Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
45UOC Ematologia e Trapianto Cellule Staminali Emopoietiche, Fondazione Policlinico Universitario A. Gemelli IRCCS Roma, Rome, Italy
46Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany
47Fred Hutchinson Cancer Center, Seattle, WA
48Department of Stem Cell Transplantation, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
49Dipartimento di Oncologia ed Ematologia, Università degli Studi di Milano, Policlinico di Milano, Ospedale Maggiore, Fondazione I.R.C.C.S. Ca Granda, Milano, Italy
50IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Istituto di Ematologia "Seràgnoli", Bologna, Italy

3:15 PM

Orly Leiva, MD1,2, Steven Soo, M.D.3*, Nathaniel Smilowitz4*, Harmony Reynolds4*, Binita Shah4*, Samuel Bernard4*, Michelle Hyunju Lee, MD5, Chi-Joan How, MD6 and Gabriela S. Hobbs, MD7

1University of Chicago, Chicago, IL
2New York University Langone Health, New York City, NY
3New York University Long Island School of Medicine, Mineola, NY
4New York University Grossman School of Medicine, New York City, NY
5Department of Medical Oncology, Massachusetts General Hospital, Boston, MA
6Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA
7Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA

*signifies non-member of ASH